ResMed (RMD) Tops Q1 EPS by 3c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $227.32 -0.48%
EPS Growth %: +5.5%
Financial Fact:
Research and development: 34.45M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +5.5%
Financial Fact:
Research and development: 34.45M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q1 EPS of $1.64, $0.03 better than the analyst estimate of $1.61. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.1 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- UBS Reiterates Neutral Rating on Intuit (INTU), Says Investor Day Not 'Sentiment-Changing'
- Circle Internet stock climbs on TD Cowen upgrade, Fed rate hike
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
